Amarin Corp Plc (AMRN)

[zmanindc]

Amarin is missing the mark on educating the street on the value of V and wall street does not get it. Consider Evaporate, in the US over 1 million people receive a stent. If the EU market is bigger that number is closer to 2 million. As a standard of care it would be in the best interest of the patient to prescribe V after the procedure. Add that to the general reduce it population and V should sell billions in the EU. I would not be surprised to see HLS push for evaporate on the Canada label. Not counting the ROW and China this stock should command at least $20 on a buyout. We troll these low levels because management is horrible. All these years and still no partners or application for approvals in some very large markets.

The lawsuit we need to consider is the one that removes the BOD and takes control of the company.